This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
OSKAR KOKOSCHKA EXPRESSIONIST, MIGRANT, ...     By Francesco Carelli, University Milan - The Leopold ... (20 Apr 2019)
Fish are accumulating certain ... The UPV/EHU-University of the Basque Country has found that ... (19 Apr 2019)
The pressure to prescribe: Antibiotic ... Outpatient healthcare providers inappropriately prescribed ... (17 Apr 2019)
Study Provides Insights on Marijuana and ... A new study reveals that many people with cancer use marijuana, ... (17 Apr 2019)
Testosterone and cortisol modulate the ... Researchers at the UPV/EHU-University of the Basque Country ... (17 Apr 2019)

A new study reveals that many people with cancer use marijuana, and rates of use in the U.S. have increased over time. The study also found that patients with cancer are more likely to use prescription opioids than adults without cancer.

Published in Medical News

New research indicates that colorectal cancer diagnosed at an early age has clinical and genetic features that are different from those seen in traditional colorectal cancer diagnosed later in life.

Published in Medical News

Many men with low-risk prostate cancer who most likely previously would have undergone immediate surgery or radiation are now adopting a more conservative “active surveillance” strategy, according to an analysis of a new federal database by scientists from Dana-Farber Cancer Institute.

Published in Medical News

Colorectal cancer is the third most common cause of cancer deaths in the United States and advanced colorectal polyps are a major risk factor. The U.S. Preventive Services Task Force (USPSTF) concluded that aspirin reduces the risk of colorectal cancer by 40 percent as well as recurrence of advanced polyps. Their guidelines suggest that, without a specific contraindication, health care providers should routinely prescribe aspirin to all patients with advanced colorectal polyps.

Published in Medical News

The immunotherapy that has revolutionized treatment of many cancers appears to offer similar benefit to cancer patients living with HIV, say researchers at Georgetown Lombardi Comprehensive Cancer Center.

Published in Medical News

Study findings lead to accelerated FDA drug approval 

The first study of the immunotherapy drug pembrolizumab as the initial treatment for patients with a rare but aggressive form of skin cancer known as Merkel cell carcinoma reports better responses and longer survival than expected with conventional chemotherapy.

Published in Medical News
Page 1 of 13

Highlights

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…